Marraffa, a former Walgreens executive, joined KPH Healthcare Services in 2019 as vice president of government affairs and healthcare services integration.
Qulipta is the first and only oral calcitonin gene-related peptide receptor antagonist (gepant) specifically developed for the preventive treatment of migraine.
Two medicines prescribed for the treatment of specific kinds of cancer and an autoinflammatory cardiovascular disease are now available through AllianceRx Walgreens Prime.